tph-1 encodes a tryptophan hydroxylase, the key enzyme for serotonin biosynthesis. When I was in Gary Ruvkun's lab, I collaborated with Martin Victor in Yang Shi's lab and isolated a
tph-1 deletion mutation,
tph-1(
mg280).
tph-1(
mg280) shows no detectable serotonin based on anti-serotonin antibody staining and exhibits several behavioral and metabolic defects (Sze et al., 2000). It has been proposed that in mammals changes in the level of TPH mRNA correlate with long-term changes in the cellular serotonin level and that the regulation of TPH mRNA tends to be "inducer"- and region-specific (Semple-Rowland et al., 1996; Clark and Russo, 1997; Siuciak et al., 1998. Bethea, et al., 2000). Thus, the regulation of TPH expression may be a key step by which the nervous system adjusts its long-term synaptic serotonin levels. To identify genes regulating
tph-1, I have started a genetic screen for mutations that alter
tph-1::gfp expression in specific neurons. Thus far, mutations identified can be classified into three classes. (1) I have previously reported that mutations in the POU-homeodomain transcription factor UNC-86 abolish
tph-1::gfp expression in NSM and HSN, but the expression in ADF is not affected. UNC-86 is expressed in HSN and NSM, but not in ADF. (2) I have identified 18 mutations where
tph-1::gfp expression in ADF is reduced or eliminated. Laser ablation of ADF and ASI causes animals to form dauers (Bargmann and Horvitz, 1993; Schackwitz et al., 1996) and the
tph-1(
mg280) mutation downregulates
daf-7::gfp expression and enhances
daf-7(
e1372) dauer formation at 15oC. To test the role of ADF-produced serotonin is important for a non-dauer growth, I am testing if these mutations enhance
daf-7(
e1372) dauer formation at 15oC. (3) I have identified one mutation that has
tph-1::gfp expressed in an extra neuron. These mutants provide me as useful means to characterize the role of serotonin produced in specific neurons.